In season 3, episode 5 of Targeted Talks, Thomas Habermann, MD, discusses the latest advances in the treatment of diffuse large B-cell lymphoma.

S3 Ep5: The Road to Improving Diffuse Large B-Cell Lymphoma Treatment

<div>Targeted Oncology brings you <em>Treating Together</em>, a podcast series designed to bring oncologists into meaningful, peer-driven conversations by focusing on real-world challenges, clinical relevance of emerging data, and bridging the gap between research and frontline oncology care across different cancer types.</div>

Science

Health & Fitness

Targeted Oncology brings you Treating Together, a podcast series designed to bring oncologists into meaningful, peer-driven conversations by focusing on real-world challenges, clinical relevance of emerging data, and bridging the gap between research and frontline oncology care across different cancer types.

Targeted Oncology brings you <em>Treating Together</em>, a podcast series designed to bring oncologists into meaningful, peer-driven conversations by focusing on real-world challenges, clinical relevance of emerging data, and bridging the gap between research and frontline oncology care across different cancer types.

Share S3 Ep5: The Road to Improving Diffuse Large B-Cell Lymphoma Treatment

Sign up to save your podcasts

S3 Ep5: The Road to Improving Diffuse Large B-Cell Lymphoma Treatment

S3 Ep5: The Road to Improving Diffuse Large B-Cell Lymphoma Treatment

More shows like Treating Together

Planet Money

Interesting Times with Ross Douthat